Pacira BioSciences, Inc. (PCRX) — Net Asset Quality Index
Pacira BioSciences, Inc. (PCRX) has a Net Asset Quality Index of 54.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.21 Billion minus total liabilities of $554.64 Million yields net assets of $653.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check PCRX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pacira BioSciences, Inc. Net Asset Quality Index Over Time (2008–2025)
This chart shows how Pacira BioSciences, Inc.'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 54.1%, representing net assets of $653.89 Million against total assets of $1.21 Billion USD. See PCRX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Pacira BioSciences, Inc. (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Pacira BioSciences, Inc. from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see PCRX stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.8% | $693.11 Million | $1.26 Billion | $571.81 Million | ▲ +4.7 pp |
| 2024 | 50.1% | $778.35 Million | $1.55 Billion | $775.17 Million | ▼ -5.2 pp |
| 2023 | 55.3% | $870.13 Million | $1.57 Billion | $704.26 Million | ▲ +9.2 pp |
| 2022 | 46.1% | $775.01 Million | $1.68 Billion | $906.19 Million | ▲ +10.9 pp |
| 2021 | 35.2% | $730.41 Million | $2.08 Billion | $1.34 Billion | ▼ -13.4 pp |
| 2020 | 48.6% | $619.69 Million | $1.27 Billion | $654.83 Million | ▲ +5.9 pp |
| 2019 | 42.7% | $354.94 Million | $831.07 Million | $476.12 Million | ▼ -3.9 pp |
| 2018 | 46.6% | $321.23 Million | $689.35 Million | $368.13 Million | ▲ +2.1 pp |
| 2017 | 44.5% | $279.48 Million | $628.37 Million | $348.89 Million | ▼ -11.5 pp |
| 2016 | 55.9% | $218.98 Million | $391.47 Million | $172.49 Million | ▼ -0.1 pp |
| 2015 | 56.1% | $218.39 Million | $389.62 Million | $171.23 Million | ▲ +3.6 pp |
| 2014 | 52.5% | $171.15 Million | $326.07 Million | $154.93 Million | ▲ +28.2 pp |
| 2013 | 24.3% | $41.25 Million | $169.82 Million | $128.57 Million | ▼ -34.5 pp |
| 2012 | 58.8% | $65.86 Million | $112.05 Million | $46.20 Million | ▲ +16.2 pp |
| 2011 | 42.5% | $48.27 Million | $113.49 Million | $65.22 Million | ▲ +115.2 pp |
| 2010 | -72.7% | $-48.38 Million | $66.56 Million | $114.94 Million | ▼ -20.5 pp |
| 2009 | -52.2% | $-22.95 Million | $43.95 Million | $66.90 Million | ▼ -67.0 pp |
| 2008 | 14.8% | $7.49 Million | $50.54 Million | $43.05 Million | — |